Vantai

Vantai company information, Employees & Contact Information

Explore related pages

Related company profiles:

VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods. For more information, please visit http://www.vant.ai.

Company Details

Employees
70
Founded
-
Address
New York, Ny 10003, Us
Phone
+1 347 633 3580
Email
hi****@****vant.ai
Industry
Biotechnology
HQ
New York, NY
Looking for a particular Vantai employee's phone or email?

Vantai Questions

News

Blueprint revises $1.67B VantAI pact again, zeroing in on molecular glue potential - Fierce Biotech

Blueprint revises $1.67B VantAI pact again, zeroing in on molecular glue potential Fierce Biotech

VantAI Links With Halda in Potential $1B+ Proteomics Pact - BioSpace

VantAI Links With Halda in Potential $1B+ Proteomics Pact BioSpace

Roivant-backed VantAI and Halda line up $1B RIPTAC pact - Endpoints News

Roivant-backed VantAI and Halda line up $1B RIPTAC pact Endpoints News

Halda Therapeutics and VantAI agree $1bn partnership for AI cancer treatment - BioXconomy

Halda Therapeutics and VantAI agree $1bn partnership for AI cancer treatment BioXconomy

VantAI, Halda Therapeutics Launch $1B+ Proximity-Based Therapy Collaboration - Genetic Engineering and Biotechnology News

VantAI, Halda Therapeutics Launch $1B+ Proximity-Based Therapy Collaboration Genetic Engineering and Biotechnology News

More than $1 billion at stake in VantAI and Halda deal - The Pharma Letter

More than $1 billion at stake in VantAI and Halda deal The Pharma Letter

VantAI Launches Neo-1, the First AI Model to Rewire Molecular Interactions by Unifying Structure Prediction and Generation for Therapeutic Design - Yahoo Finance

VantAI Launches Neo-1, the First AI Model to Rewire Molecular Interactions by Unifying Structure Prediction and Generation for Therapeutic Design Yahoo Finance

VantAI looking to rewrite drug discovery rules with Neo-1 system - FirstWord Pharma

VantAI looking to rewrite drug discovery rules with Neo-1 system FirstWord Pharma

Blueprint Medicines and VantAI to advance novel therapies with expanded agreement - World Pharmaceutical Frontiers

Blueprint Medicines and VantAI to advance novel therapies with expanded agreement World Pharmaceutical Frontiers

Crowell & Moring Represents Halda Therapeutics in Landmark Alliance With VantAI To Discover Next-Generation RIPTAC Medicines - Crowell & Moring LLP

Crowell & Moring Represents Halda Therapeutics in Landmark Alliance With VantAI To Discover Next-Generation RIPTAC Medicines Crowell & Moring LLP

Exclusive: Roivant-backed VantAI debuts AI model Neo-1, taking ‘the big next step’ after AlphaFold 3 - Endpoints News

Exclusive: Roivant-backed VantAI debuts AI model Neo-1, taking ‘the big next step’ after AlphaFold 3 Endpoints News

Vanta Raises $150M Series D to Power the Future of AI-Driven Trust - Business Wire

Vanta Raises $150M Series D to Power the Future of AI-Driven Trust Business Wire

Wellington-led funding boosts Vanta's valuation by 69% in a year - Reuters

Wellington-led funding boosts Vanta's valuation by 69% in a year Reuters

BMS signs $674m GenAI drug discovery deal with VantAI - Pharmaceutical Technology

BMS signs $674m GenAI drug discovery deal with VantAI Pharmaceutical Technology

VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen - GlobeNewswire

VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen GlobeNewswire

BMS signs $674M biobucks pact with Roivant-backed VantAI for molecular glues - Fierce Biotech

BMS signs $674M biobucks pact with Roivant-backed VantAI for molecular glues Fierce Biotech

VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence - Business Wire

VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence Business Wire

VantAI Inks Second Big Protein Degrader Collab in as Many Weeks - BioSpace

VantAI Inks Second Big Protein Degrader Collab in as Many Weeks BioSpace

VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders - GlobeNewswire

VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders GlobeNewswire

VantAI Expands Scientific Advisory Board with Leaders in Protein Design and Generative AI - Business Wire

VantAI Expands Scientific Advisory Board with Leaders in Protein Design and Generative AI Business Wire

This $674 Million Deal Aims To Turn Your Body's Garbage Disposal Into A Disease Fighter - Forbes

This $674 Million Deal Aims To Turn Your Body's Garbage Disposal Into A Disease Fighter Forbes

VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer - citybiz

VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer citybiz

Roivant gets $200M for major push into protein degradation - Fierce Biotech

Roivant gets $200M for major push into protein degradation Fierce Biotech

Roivant Announces Protein Degradation Platform Using VantAI Against Difficult Drug Targets - BioSpace

Roivant Announces Protein Degradation Platform Using VantAI Against Difficult Drug Targets BioSpace

TARA Biosystems and VantAI team up to accelerate drug development for cardiac disease - News-Medical

TARA Biosystems and VantAI team up to accelerate drug development for cardiac disease News-Medical

NVIDIA Opens BioNeMo to Scale Digital Biology for Global Biopharma and Scientific Industry - NVIDIA Newsroom

NVIDIA Opens BioNeMo to Scale Digital Biology for Global Biopharma and Scientific Industry NVIDIA Newsroom

Predict First: BMS Executives Discuss Company’s AI Approach - Genetic Engineering and Biotechnology News

Predict First: BMS Executives Discuss Company’s AI Approach Genetic Engineering and Biotechnology News

Vantai, Bristol Myers Squibb collaborate on molecular glues - BioWorld MedTech

Vantai, Bristol Myers Squibb collaborate on molecular glues BioWorld MedTech

Halda boosts its proximity approach | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Halda boosts its proximity approach | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Bristol Myers Squibb launches $674M drug discovery partnership with city biotech - Crain's New York Business

Bristol Myers Squibb launches $674M drug discovery partnership with city biotech Crain's New York Business

Roivant Sciences to absorb Silicon Therapeutics with $450M-plus deal - Fierce Biotech

Roivant Sciences to absorb Silicon Therapeutics with $450M-plus deal Fierce Biotech

Where AI meets biology - Drug Discovery News

Where AI meets biology Drug Discovery News

Targeting protein–ligand neosurfaces with a generalizable deep learning tool - Nature

Targeting protein–ligand neosurfaces with a generalizable deep learning tool Nature

Blueprint marks protein degrader path in $632M biobucks pact with a Vant - Fierce Biotech

Blueprint marks protein degrader path in $632M biobucks pact with a Vant Fierce Biotech

Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics - PR Newswire

Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics PR Newswire

Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility (ROIV) - Seeking Alpha

Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility (ROIV) Seeking Alpha

Blueprint Medicines and Proteovant Therapeutics Announce Strategic Collaboration to Advance Novel Targeted Protein Degrader Therapies - PR Newswire

Blueprint Medicines and Proteovant Therapeutics Announce Strategic Collaboration to Advance Novel Targeted Protein Degrader Therapies PR Newswire

Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy (NASDAQ:ROIV) - Seeking Alpha

Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy (NASDAQ:ROIV) Seeking Alpha

Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant - BioPharma Dive

Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant BioPharma Dive

Merck KGaA taps AI-focused biotech for new ADC pact worth $376M - Fierce Biotech

Merck KGaA taps AI-focused biotech for new ADC pact worth $376M Fierce Biotech

npm Packages from rspack, vant Compromised, Blocked by Sonatype - Sonatype

npm Packages from rspack, vant Compromised, Blocked by Sonatype Sonatype

Roivant Sciences: Vant Model And IMVT-1402 Create A 2025 Catalyst Stack (NASDAQ:ROIV) - Seeking Alpha

Roivant Sciences: Vant Model And IMVT-1402 Create A 2025 Catalyst Stack (NASDAQ:ROIV) Seeking Alpha

Pfizer, Roivant team up for new inflammatory-focused Vant—and no, they're not calling it Pfvant - Fierce Biotech

Pfizer, Roivant team up for new inflammatory-focused Vant—and no, they're not calling it Pfvant Fierce Biotech

New year, new models: AI predictions for 2024 - CSIRO

New year, new models: AI predictions for 2024 CSIRO

Emerging Pharma: Roivant Sciences on the Rise - DCAT Value Chain Insights

Emerging Pharma: Roivant Sciences on the Rise DCAT Value Chain Insights

Roivant Appoints Chief Development Officer and Announces Multiple Collaborations in Targeted Protein Degradation - GlobeNewswire

Roivant Appoints Chief Development Officer and Announces Multiple Collaborations in Targeted Protein Degradation GlobeNewswire

Datavant and Boehringer Ingelheim Expand Partnership to Fuel Scalable Real-World Evidence Infrastructure - Business Wire

Datavant and Boehringer Ingelheim Expand Partnership to Fuel Scalable Real-World Evidence Infrastructure Business Wire

Roivant’s move to go public reveals just how much its drug strategy has changed - MedCity News

Roivant’s move to go public reveals just how much its drug strategy has changed MedCity News

Roivant Sciences Sells Joint Venture With Pfizer to Roche for $7.1 Billion - Investopedia

Roivant Sciences Sells Joint Venture With Pfizer to Roche for $7.1 Billion Investopedia

A new portfolio model for biotech - McKinsey & Company

A new portfolio model for biotech McKinsey & Company

A Story About Roivant, Axovant, and Myovant - Nanalyze

A Story About Roivant, Axovant, and Myovant Nanalyze

Sander van 't Noordende leaves Accenture after 32 years - Consultancy.eu

Sander van 't Noordende leaves Accenture after 32 years Consultancy.eu

Super League Roundup: All Top Teams Secure Wins, Van’t Schip Returns to Greece - - Greek City Times

Super League Roundup: All Top Teams Secure Wins, Van’t Schip Returns to Greece - Greek City Times

Lucio Ribeiro, Vijay Solanki create Innovator series: Bridging the gap between startups and corporates with AI - Mi-3.com.au

Lucio Ribeiro, Vijay Solanki create Innovator series: Bridging the gap between startups and corporates with AI Mi-3.com.au

To break through the adoption barrier, Australia's biggest companies must lead the charge on Gen AI governance - Mi-3.com.au

To break through the adoption barrier, Australia's biggest companies must lead the charge on Gen AI governance Mi-3.com.au

Vant Panels Reviews- Decorative Wall Paneling - Family Focus Blog

Vant Panels Reviews- Decorative Wall Paneling Family Focus Blog

New Music Of The Day: VANT – ‘Do You Know Me?’ - NME

New Music Of The Day: VANT – ‘Do You Know Me?’ NME

Romanian song of the week: ROA – Aripi in vant (Wings in the wind) - Romania Insider

Romanian song of the week: ROA – Aripi in vant (Wings in the wind) Romania Insider

VANT announce split - NME

VANT announce split NME

Ubuntu Laptops from VANT Get Intel Kaby Lake Refresh - OMG! Ubuntu

Ubuntu Laptops from VANT Get Intel Kaby Lake Refresh OMG! Ubuntu

SoftBank invests $1.1 billion in Indian-origin entrepreneur’s Roivant Sciences - The News Minute

SoftBank invests $1.1 billion in Indian-origin entrepreneur’s Roivant Sciences The News Minute

18. Maggie Van’T Hoff, General manager, retail IT at Shell - The 50 most influential women in UK IT 2015 - Computer Weekly

18. Maggie Van’T Hoff, General manager, retail IT at Shell - The 50 most influential women in UK IT 2015 Computer Weekly

Gallery: VANT // Scala, London – 29.11.16 - The Indiependent

Gallery: VANT // Scala, London – 29.11.16 The Indiependent

Top 5 AI & Digital Biotech Companies (October 2025) - Securities.io

Top 5 AI & Digital Biotech Companies (October 2025) Securities.io

Top Vantai Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant